Last updated on : 10 Nov, 2025
Read time : 8 min
Anti-Müllerian Hormone (AMH) plays a crucial role in assessing a woman’s fertility potential. It serves as a reliable indicator of the number of eggs remaining in the ovaries, known as the ovarian reserve [1]. By understanding AMH levels, women and their doctors can gain insights into ovarian reserve and potential response to fertility treatments.
Let’s delve deeper into what AMH is and how it relates to fertility.
AMH is a hormone secreted by the granulosa cells found in the ovarian follicles. It provides valuable insights into a woman’s ovarian reserve by measuring the number of small, growing follicles (primordial and preantral) in the ovaries [2]. Unlike many other hormones that fluctuate throughout the menstrual cycle, AMH levels remain relatively stable, offering a consistent and reliable measure of the remaining egg supply [3]. This measurement primarily helps assess a woman’s reproductive lifespan and is a key factor in guiding fertility treatment discussions with doctors. Now, let’s explore what constitutes a typical AMH level.
A good AMH level generally indicates a healthy ovarian reserve. However, it’s important to note that AMH measures the quantity of eggs, not the quality, which is primarily linked to age.
It’s crucial to understand that AMH levels naturally decline with age.
As women age, their ovarian reserve naturally declines, and consequently, their AMH levels decrease.
AMH levels are primarily a tool for assessing ovarian reserve and planning fertility treatments; they are not a direct predictor of natural conception success.
The Role of AMH in Natural Pregnancy
Although low AMH levels can indicate a reduced ovarian reserve, pregnancy is still achievable through ART, such as IVF. The main implication of low AMH in IVF is that it predicts a lower yield of eggs during the retrieval process, which can impact the number of viable embryos available [5]. Fertility protocols can be tailored to maximize the response in women with low AMH [3].
Elevated AMH levels, often above 4.0 ng/mL, may indicate a very high ovarian reserve.
AMH testing involves a straightforward blood draw to measure the level of AMH in your bloodstream. No specific dietary restrictions or fasting are required [3]. The test results allow healthcare providers to evaluate your ovarian function and, combined with other factors like age and Antral Follicle Count (AFC), tailor a treatment plan to your specific needs [1]. Only a healthcare professional can interpret AMH results accurately in the context of overall fertility health.
The scientific consensus suggests that AMH is a reflection of the existing number of follicles (ovarian reserve) and cannot be significantly increased [3]. However, focusing on overall health may optimize the function of the remaining follicles:
Conclusion
AMH levels are a crucial biomarker for assessing ovarian reserve and predicting a woman’s likely response to fertility treatments. While high levels suggest a good quantity of eggs, and low levels indicate a reduced reserve, AMH alone does not determine the ability to conceive naturally. Fertility success depends on a complex interplay of factors, including age, egg quality, and ovulation regularity. Consulting with your healthcare provider is essential for accurately interpreting your AMH results and exploring the comprehensive fertility options available to you.
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional, such as an OB-GYN or Reproductive Specialist, for personalized diagnosis and treatment plans.
Normal AMH levels typically range from 1.0 to 4.0 ng/mL in women of reproductive age. However, the interpretation is highly dependent on the woman’s age and overall clinical picture [2].
Yes, pregnancy is possible even with low AMH levels. Low AMH indicates a smaller egg supply (lower ovarian reserve) but does not mean the remaining eggs are non-viable.
High AMH levels (often above 4.0 ng/mL) suggest a large ovarian reserve and are commonly seen in women with Polycystic Ovary Syndrome (PCOS) [4].
No, AMH is not the only test for fertility. It is a key indicator of ovarian reserve, but other essential tests include Antral Follicle Count (AFC) via ultrasound, and hormone tests for FSH, Estradiol, and Progesterone [1].
Yes, AMH levels naturally and predictably decrease with age [2]. They do not typically fluctuate significantly month-to-month but reflect the gradual, age-related decline in ovarian reserve.
[1] Deadmond, A., Koch, C. A., & Parry, J. P. (2020). Ovarian reserve testing. In Endotext. MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK279058/
[2] Moolhuijsen, L. M. E., & Visser, J. A. (2020). Anti-müllerian hormone and ovarian reserve: Update on assessing ovarian function. The Journal of Clinical Endocrinology and Metabolism, 105(11), 3361–3373. https://doi.org/10.1210/clinem/dgaa513
[3] Cedars, M. I. (2022). Evaluation of female fertility—AMH and ovarian reserve testing. The Journal of Clinical Endocrinology & Metabolism, 107(6), 1510-1519. https://academic.oup.com/jcem/article-abstract/107/6/1510/6518212
[4] Gowkielewicz, M., Lipka, A., Zdanowski, W., Waśniewski, T., Majewska, M., & Carlberg, C. (2024). Anti-Müllerian hormone: biology and role in endocrinology and cancers. Frontiers in Endocrinology, 15, 1468364. https://doi.org/10.3389/fendo.2024.1468364
[5] La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010). Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reproduction Update, 16(2), 113–130. https://doi.org/10.1093/humupd/dmp036
[6] Shrikhande, L., Shrikhande, B., & Shrikhande, A. (2020). AMH and its clinical implications. Journal of Obstetrics and Gynaecology of India, 70(5), 337–341. https://doi.org/10.1007/s13224-020-01362-0
[7] Iwase, A., Asada, Y., Sugishita, Y., Osuka, S., Kitajima, M., Kawamura, K., & from the subcommittee “Survey of AMH measurement in Japan” in Reproductive Endocrinology Committee, Japan Society of Obstetrics and Gynecology, 2021-2022. (2024). Anti-Müllerian hormone for screening, diagnosis, evaluation, and prediction: A systematic review and expert opinions. The Journal of Obstetrics and Gynaecology Research, 50(1), 15–39. https://doi.org/10.1111/jog.15818
[8] Bedaiwy, M. A., & Al-Nasr, I. (2014). Nutrition and lifestyle changes for improving fertility and reducing the risk of assisted reproductive technology complications. Reproductive Biology and Endocrinology, 12, 118. https://doi.org/10.1186/1477-7827-12-118
Disclaimer
Our healthcare experts have carefully reviewed and compiled the information presented here to ensure accuracy and trustworthiness. It is important to note that this information serves as a general overview of the topic and is for informational purposes only. It is not intended to diagnose, prevent, or cure any health problem. This page does not establish a doctor-patient relationship, nor does it replace the advice or consultation of a registered medical practitioner. We recommend seeking guidance from your registered medical practitioner for any questions or concerns regarding your medical condition.
Company
About UsHealth ArticleHealth StoriesDiseases & Health ConditionsAyurvedaAll MedicinesAll BrandsNeed HelpFAQSecuritySubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.8.1
2025 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners

